Trial reportBMC anesthesiology2026
Effect of supraglottic endotracheal tube inserted transorally on preventing hypoxemia in obese patients undergoing sedated bidirectional endoscopy: a prospective randomized controlled clinical trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevention of hypoxemia in obese patients undergoing sedated gastroscopy is challenging, mainly due to upper airway obstruction. This study used a transorally inserted supraglottic endotracheal tube as an oropharyngeal airway to improve ventilation during sedated bidirectional endoscopy (esophagogastroduodenoscopy followed by colonoscopy) in patients with obesity.
methodsPatients with mild-to-moderate obesity (body mass index: 30–39.9 kg/m2) underwent bidirectional endoscopy during deep sedation and received supplemental oxygen via a modified oropharyngeal airway using an endotracheal tube (ETT-OA) (n = 97) or a nasopharyngeal airway (n = 96). An endotracheal tube was inserted through the side port of the endoscopic bite block into the supraglottic area under gastroscopic guidance. The primary outcomes were the incidence of hypoxemia and severe hypoxemia.
resultsThe minimum SpO2 was comparable between the two groups. The incidence of hypoxemia was significantly lower in the oropharyngeal airway group than in the nasopharyngeal airway group (4.1% vs. 14.6%, P = 0.012). Severe hypoxemia occurred in six patients in the nasopharyngeal airway group but not in the other group (P = 0.037). The distal end of the nasopharyngeal airway was not inserted into the supraglottic area in eight patients because the tube was short and could not be replaced with a larger-sized tube due to rhinostenosis. Epistaxis occurred in 12 (12.5%) patients in the nasopharyngeal airway group. Anesthesiologists and endoscopists were more satisfied with the oropharyngeal airway.
conclusionsAn ETT-OA reduced the incidence of hypoxemia, especially severe hypoxemia, in patients with mild-to-moderate obesity during sedated bidirectional endoscopy compared with a nasopharyngeal airway.
trial registrationChinese Clinical Trial Registry (ChiCTR2200064417), first registered on 07/10/2022.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.